NCT04801290 TIPS in Patients With Decompensated Liver Cirrhosis
| NCT ID | NCT04801290 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hannover Medical School |
| Condition | Decompensated Liver Cirrhosis |
| Study Type | OBSERVATIONAL |
| Enrollment | 250 participants |
| Start Date | 2019-08-29 |
| Primary Completion | 2027-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 250 participants in total. It began in 2019-08-29 with a primary completion date of 2027-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a single center patient registry of patients receiving a transjugular intrahepatic portosystemic shunt (TIPS) at Hannover Medical School. By collecting and analyzing clinical data as well as blood samples, the overall aim is to optimize TIPS therapy (e.g. specify selection criteria).
Eligibility Criteria
Inclusion Criteria: * Liver cirrhosis * Indication for TIPS insertion * Treatment at the Department of Gastroenterology, Hepatology and Endocrinology of Hannover Medical School * Informed consent Exclusion Criteria: * Pregnancy or Lactation * Age \<18 years * Lack of Informed consent * Symptomatic anemia with Hb \<7g/dl
Contact & Investigator
Benjamin Maasoumy, PD
PRINCIPAL INVESTIGATOR
Hannover Medical School
Frequently Asked Questions
Who can join the NCT04801290 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 99 Years, studying Decompensated Liver Cirrhosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04801290 currently recruiting?
Yes, NCT04801290 is actively recruiting participants. Contact the research team at Maasoumy.Benjamin@mha-hannover.de for enrollment information.
Where is the NCT04801290 trial being conducted?
This trial is being conducted at Hanover, Germany.
Who is sponsoring the NCT04801290 clinical trial?
NCT04801290 is sponsored by Hannover Medical School. The principal investigator is Benjamin Maasoumy, PD at Hannover Medical School. The trial plans to enroll 250 participants.